ARID1A and TERT promoter mutations in dedifferentiated meningioma

While WHO grade I meningiomas are considered benign, patients with WHO grade III meningiomas have very high mortality. The principles underlying tumor progression in meningioma are largely unknown yet a detailed understanding of these mechanisms will be required for effective management of patients...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer Genet
Egile Nagusiak: Abedalthagafi, Malak S., Bi, Wenya Linda, Merrill, Parker H., Gibson, William J., Rose, Matthew F., Du, Ziming, Francis, Joshua M., Du, Rose, Dunn, Ian F., Ligon, Azra H., Beroukhim, Rameen, Santagata, Sandro
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2015
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4882906/
https://ncbi.nlm.nih.gov/pubmed/25963524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cancergen.2015.03.005
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak